William Lewis, MD

Article

Symmetrical drug-related intertriginous and flexural exanthema in the gluteal cleft of a 65-year-old man 2 weeks after starting lazertinib and amivantamab therapy for stage IV non–small cell lung cancer.

Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?

Author:: William Lewis, MD; Amy Forrestel, MD; Emily Baumrin, MD

Symmetrical drug-related intertriginous and flexural exanthema is an uncommon but increasingly recognized cutaneous adverse event of epidermal...

Read More

Article

Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic

Author:: Mariam Alam, MD; William Lewis, MD; Joanna Harp, MD; Katherine Steele, MD; Misha Rosenbach, MD; Robert G. Micheletti, MD

Cutaneous manifestations of COVID-19 may reflect the range of host immunologic responses to SARS-CoV-2.

Read More